ロード中...
Rapid enrollment design for finding the optimal dose in immunotherapy trials with ordered groups
In immunotherapy dose-finding trials, the optimal dose is usually defined based on both toxicity and response because the relationship between toxicity and response is different than that seen with cytotoxic antineoplastic therapies. In immunotherapy trials, toxicity and response often require a lon...
保存先:
| 出版年: | J Biopharm Stat |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791120/ https://ncbi.nlm.nih.gov/pubmed/31251112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2019.1633654 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|